石药集团：Accelerating growth in finished drug sales

M N 28 May 2024 CMB International Global Markets | Equity Research | Company Update CSPC Pharmaceutical (1093 HK) Accelerating growth in finished drug sales  Strong double-digit growth in 1Q24. CSPC reported 1Q24 revenue of Target Price HK $8.51 RMB8.98bn (+11.5% YoY, +18.4% QoQ) and attributable net profit of (Previous TP HK$ 7.76) RMB1.61bn (+12.9% YoY, +17.0% QoQ), regaining double-digit growth, and Up/Downside 21.0% representing 26% and 20% of our previous full-year estimates, respectively. Current Price ...